93 related articles for article (PubMed ID: 14625172)
21. Explorations of post-gDLI low-dose cyclophosphamide for preventing severe aGVHD.
Chen X; Zheng X; Lu N; Zhang R; Zhai W; Ma Q; Pang A; Yang D; Wei J; He Y; Feng S; Han M; Jiang E
Int Immunopharmacol; 2023 Dec; 125(Pt A):111165. PubMed ID: 37935091
[TBL] [Abstract][Full Text] [Related]
22. Risk factors for hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation in a letermovir-exposed CMV-free population receiving PTCy.
Galli E; Metafuni E; Gandi C; Limongiello MA; Giammarco S; Mattozzi A; Santangelo R; Bacigalupo A; Sorà F; Chiusolo P; Sica S
Eur J Haematol; 2024 Apr; 112(4):577-584. PubMed ID: 38183299
[TBL] [Abstract][Full Text] [Related]
23. Ruxolitinib Therapy Followed by Reduced-Intensity Conditioning for Hematopoietic Cell Transplantation for Myelofibrosis: Myeloproliferative Disorders Research Consortium 114 Study.
Gupta V; Kosiorek HE; Mead A; Klisovic RB; Galvin JP; Berenzon D; Yacoub A; Viswabandya A; Mesa RA; Goldberg J; Price L; Salama ME; Weinberg RS; Rampal R; Farnoud N; Dueck AC; Mascarenhas JO; Hoffman R
Biol Blood Marrow Transplant; 2019 Feb; 25(2):256-264. PubMed ID: 30205231
[TBL] [Abstract][Full Text] [Related]
24. Mycophenolate mofetil increases the risk of diarrhea in allogeneic hematopoietic stem cell transplantation recipients.
Lin L; Hong M; Fu X
J Int Med Res; 2023 Oct; 51(10):3000605231206968. PubMed ID: 37879636
[TBL] [Abstract][Full Text] [Related]
25. Influence of interruption of oral mycophenolate mofetil for graft-versus-host disease prophylaxis on outcomes after single cord blood transplantation.
Fukushi K; Monna-Oiwa M; Kato S; Isobe M; Kuroda S; Nannya Y; Takahashi S; Konuma T
Blood Cell Ther; 2024 May; 7(2):41-48. PubMed ID: 38854401
[TBL] [Abstract][Full Text] [Related]
26. Mini-dose methotrexate combined with methylprednisolone for the initial treatment of acute GVHD: a multicentre, randomized trial.
Wang Y; Liu QF; Wu DP; Xu ZL; Han TT; Sun YQ; Huang F; Fan ZP; Xu N; Chen F; Zhao Y; Kong Y; Mo XD; Xu LP; Zhang XH; Liu KY; Huang XJ
BMC Med; 2024 Apr; 22(1):176. PubMed ID: 38664766
[TBL] [Abstract][Full Text] [Related]
27. Reaching the cyclosporine a level target slowly in four weeks correlates with better prognosis for Chinese patients after allogeneic haematopoietic cell transplantation.
Fan Q; Hui X; Li X; Li Q; Yang D; Wang Y
Hematology; 2023 Dec; 28(1):2275893. PubMed ID: 37975575
[TBL] [Abstract][Full Text] [Related]
28. Post-transplant cyclophosphamide with Sirolimus or Cyclosporine for GvHD prophylaxis in matched related and unrelated transplantation: a two-center analysis on 213 consecutive patients.
Piemontese S; Lupo Stanghellini MT; Sora F; Sica S; Peccatori J; Marcatti M; Metafuni E; Giammarco S; Greco R; Bruno A; Ciceri F; Bacigalupo A; Chiusolo P
Bone Marrow Transplant; 2024 May; 59(5):692-694. PubMed ID: 38355909
[No Abstract] [Full Text] [Related]
29. Consecutive Liver and Bone Marrow Transplantation for Erythropoietic Protoporphyria: Case Report and Literature Review.
Portich JP; Ribeiro AS; Rodrigues Taniguchi AN; Backes A; de Souza CFM; Kieling CO; Scherer FF; de Oliveira Poswar F; Leipnitz I; Doederlein Schwartz IV; Sekine L; Rigoni LDC; Marquardt da Silveira L; de Almeida Furlanetto M; Adami MR; Breunig RC; Guedes RR; do Amaral SN; Gonçalves Vieira SM; de Brum Soares T; Silva TO; da Rocha Silla LM; Astigarraga CC; Paz AA; Daudt LE
J Pediatr Hematol Oncol; 2023 Oct; 45(7):416-422. PubMed ID: 37539993
[TBL] [Abstract][Full Text] [Related]
30. High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis.
Nash RA; Bowen JD; McSweeney PA; Pavletic SZ; Maravilla KR; Park MS; Storek J; Sullivan KM; Al-Omaishi J; Corboy JR; DiPersio J; Georges GE; Gooley TA; Holmberg LA; LeMaistre CF; Ryan K; Openshaw H; Sunderhaus J; Storb R; Zunt J; Kraft GH
Blood; 2003 Oct; 102(7):2364-72. PubMed ID: 12763935
[TBL] [Abstract][Full Text] [Related]
31. Body Surface Area-Based Dosing of Mycophenolate Mofetil in Pediatric Hematopoietic Stem Cell Transplant Recipients: A Prospective Population Pharmacokinetic Study.
Park HJ; Hong KT; Han N; Kim IW; Oh JM; Kang HJ
Pharmaceutics; 2023 Dec; 15(12):. PubMed ID: 38140082
[TBL] [Abstract][Full Text] [Related]
32. Elevation of tacrolimus concentration after administration of methotrexate for treatment of graft-versus-host disease in pediatric patients received allogeneic hematopoietic stem cell transplantation.
Inoue C; Yamamoto T; Miyata H; Suzuki H; Takada T
J Pharm Health Care Sci; 2023 Dec; 9(1):38. PubMed ID: 38049906
[TBL] [Abstract][Full Text] [Related]
33. Antiviral activity of immunosuppressors alone and in combination against human adenovirus and cytomegalovirus.
Carretero-Ledesma M; Aguilar-Guisado M; Berastegui-Cabrera J; Balsera-Manzanero M; Pachón J; Cordero E; Sánchez-Céspedes J
Int J Antimicrob Agents; 2024 May; 63(5):107116. PubMed ID: 38401774
[TBL] [Abstract][Full Text] [Related]
34. Assessment of Risk Factors for Acute Kidney Injury with Machine Learning Tools in Children Undergoing Hematopoietic Stem Cell Transplantation.
Musiał K; Stojanowski J; Augustynowicz M; Miśkiewicz-Migoń I; Kałwak K; Ussowicz M
J Clin Med; 2024 Apr; 13(8):. PubMed ID: 38673539
[No Abstract] [Full Text] [Related]
35. Pulmonary Histopathologic Findings in Pediatric Patients After Hematopoietic Stem Cell Transplantation: An Autopsy Study.
Cortes-Santiago N; Patel KR; Wu H; Sartain SE; Bhar S; Silva-Carmona M; Pogoriler J
Pediatr Dev Pathol; 2023; 26(4):362-373. PubMed ID: 37165556
[TBL] [Abstract][Full Text] [Related]
36. Seizures in children undergoing stem cell transplantation.
Turón-Viñas E; López-Torija I; Coca-Fernández E; Badell I; Sierra-Marcos A; Turón M; Ribosa-Nogué R; Boronat S
Pediatr Transplant; 2024 Feb; 28(1):e14619. PubMed ID: 37803946
[TBL] [Abstract][Full Text] [Related]
37. [Quadruple therapy with CsA, MTX, MMF and ATG for preventing graft-versus-host disease in unrelated donor hematopoietic stem cell transplantation].
Liu QF; Sun J; Zhang Y; Xu D; Liu XL; Xu B; Meng FY; Zhou SY
Di Yi Jun Yi Da Xue Xue Bao; 2003 Nov; 23(11):1143-5. PubMed ID: 14625172
[TBL] [Abstract][Full Text] [Related]
38. [Hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia].
Liu QF; Sun J; Zhang Y; Liu XL; Xu D; Xu B; Feng R; Meng FY; Zhou SY
Ai Zheng; 2004 Apr; 23(4):426-9. PubMed ID: 15087032
[TBL] [Abstract][Full Text] [Related]
39. [Prophylactic effect of CsA, MTX, MMF combined with ATG on GVHD in patients underwent unrelated peripheral blood hematopoietic stem cell transplantation].
Li XH; Gao CJ; Da WM; Yu L; Wu XX; Li HH; Ma J; Cao YB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Apr; 18(2):458-62. PubMed ID: 20416188
[TBL] [Abstract][Full Text] [Related]
40. [Therapeutic efficacy of hematopoietic stem cell transplantation in patients with chronic myelogenous leukemia].
Liu QF; Fan ZP; Sun J; Zhang Y; Liu XL; Xu D; Xu B; Feng R; Meng FY; Zhou SY
Di Yi Jun Yi Da Xue Xue Bao; 2004 Nov; 24(11):1227-9, 1241. PubMed ID: 15567763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
